Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2013; 19(36): 6077-6083
Published online Sep 28, 2013. doi: 10.3748/wjg.v19.i36.6077
Table 1 Baseline, tumor characteristics, and overall and tumor-free survival rates of the liver transplantation recipients
Milan criteriaIn up-to-seven criteriaOut up-to-seven criteriaP valueP valueP value
(Group 1), n = 58(Group 2), n = 90(Group 3) n = 1201 vs 22 vs 31 vs 3
Baseline characteristics
Gender (M/F)51/781/9109/110.8590.6480.552
Age (yr)48.4 ± 10.946.8 ± 10.845.4 ± 10.00.3900.3150.067
BMI (kg/m2)23.3 ± 2.423.5 ± 2.323.3 ± 2.00.7150.7390.963
Underlying LD0.7750.4520.312
HBV548378
HCV011
No hepatic virus4616
HBV-DNA(-/+)29/3945/4582/380.8380.0700.174
DDLT/LDLT36/2262/2898/230.3930.0220.003
Child score (A/B/C)29/16/1349/23/1866/37/170.4920.6710.259
Meld score12.6 ± 6.311.8 ± 6.310.8 ± 5.20.4300.2420.051
Donor Characteristics
Donor age (yr)37.2 ± 10.237.4 ± 11.436.9 ± 9.80.8920.5580.782
Donor BMI (kg/m2)22.6 ± 3.122.7 ± 3.523.5 ± 3.60.9210.6720.691
Donor risk index1.441.411.490.7210.3220.675
Tumor characteristics
Total diameter (cm)4.1 ± 1.54.4 ± 1.811.7 ± 4.40.3070.0000.000
Number (1/2/3/4-5/diffuse)43/13/2/0/054/18/3/15/049/17/11/9/340.0240.0000.000
AFP level (ng/mL)1361.7 ± 4633.11122.4 ± 3764.52320.6 ± 10672.40.7350.3160.520
Overall survival rate0.0360.0010.000
1 yr94.80%87.80%75%
3 yr91.40%77.80%53.30%
5 yr89.70%76.60%50%
Tumor-free survival rate0.0460.0000.000
1 yr91.40%85.60%65.80%
3 yr86.20%75.60%42.50%
5 yr86.20%75.60%41.70%
Table 2 Site of hepatocellular carcinoma recurrence or metastasis after liver transplantation
LiverLungBoneLiver + lungLung + boneIntra-abdominalOther
Milan group3101000
In up-to-seven group8314000
Out up-to-seven group1621191043